Blue Coat Systems
Symbol:
BCSI
Class Period:
Status:
Investigating
Documents:
Pomerantz is investigating claims on behalf of investors of Blue Coat Systems, Inc. (“Blue Coat” or the “Company”) (NASDAQ:BCSI) concerning the proposed acquisition of Blue Coat by Thoma Bravo, LLC in a cash transaction valued at approximately $1.3 billion.
The investigation concerns whether the board of directors are breaching their fiduciary duties by failing to adequately shop the Company and maximize shareholder value. Under the terms of the agreement, Blue Coat shareholders would receive $25.81 per share in cash. However, a research analyst has set a target share price of $28.00 per share. Moreover, Blue Coat traded higher than the offer price for a majority of the first two quarters of 2011, and has traded as high as $32.
Blue Coat shareholders seeking more information about this acquisition are advised to contact Gustavo Bruckner, Esq. at gfbruckner [at] pomlaw [dot] com or 212-661-1100 or toll free at 888-476-6529, ext. 302. Shareholders may also contact Rachelle R. Boyle at rrboyle [at] pomlaw [dot] com or 212-661-1100 or 888-476-6529, ext. 237.
